- Home
- MHH vs MIRM Comparison
MHH vs MIRM Comparison
Compare MHH & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- MIRM
- Stock Information
- Founded
- MHH 1986
- MIRM 2018
- Country
- MHH United States
- MIRM United States
- Employees
- MHH N/A
- MIRM N/A
- Industry
- MHH Professional Services
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- MIRM Health Care
- Exchange
- MHH Nasdaq
- MIRM Nasdaq
- Market Cap
- MHH 78.2M
- MIRM 2.5B
- IPO Year
- MHH N/A
- MIRM 2019
- Fundamental
- Price
- MHH $7.49
- MIRM $52.66
- Analyst Decision
- MHH
- MIRM Strong Buy
- Analyst Count
- MHH 0
- MIRM 9
- Target Price
- MHH N/A
- MIRM $66.22
- AVG Volume (30 Days)
- MHH 22.4K
- MIRM 456.2K
- Earning Date
- MHH 08-06-2025
- MIRM 08-06-2025
- Dividend Yield
- MHH N/A
- MIRM N/A
- EPS Growth
- MHH N/A
- MIRM N/A
- EPS
- MHH 0.17
- MIRM N/A
- Revenue
- MHH $200,437,000.00
- MIRM $379,251,000.00
- Revenue This Year
- MHH $1.22
- MIRM $35.83
- Revenue Next Year
- MHH $5.41
- MIRM $16.83
- P/E Ratio
- MHH $42.67
- MIRM N/A
- Revenue Growth
- MHH 3.93
- MIRM 69.31
- 52 Week Low
- MHH $6.20
- MIRM $36.17
- 52 Week High
- MHH $16.00
- MIRM $54.23
- Technical
- Relative Strength Index (RSI)
- MHH 57.56
- MIRM 64.66
- Support Level
- MHH $6.86
- MIRM $49.22
- Resistance Level
- MHH $8.15
- MIRM $53.86
- Average True Range (ATR)
- MHH 0.62
- MIRM 1.57
- MACD
- MHH 0.10
- MIRM 0.08
- Stochastic Oscillator
- MHH 59.01
- MIRM 79.63
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.